Global Hemophilia Treatment Market Growth (Status and Outlook) 2022-2028
- LP 4853817
- 87 Pages
- February 2022
- Pharmaceuticals
The United States Hemophilia Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hemophilia Treatment market, reaching US$ million by the year 2028. As for the Europe Hemophilia Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Hemophilia Treatment players cover CSL Behring, Baxalta, Pfizer Inc, and BioMarin, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemophilia Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
On-demand
Prophylaxis
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Replacement Therapy
ITI Therapy
Gene Therapy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
CSL Behring
Baxalta
Pfizer Inc
BioMarin
Bayer Healthcare
Biogen
Novo Nordisk
Roche
Takeda
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hemophilia Treatment Market Size 2017-2028
2.1.2 Hemophilia Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Hemophilia Treatment Segment by Type
2.2.1 On-demand
2.2.2 Prophylaxis
2.3 Hemophilia Treatment Market Size by Type
2.3.1 Hemophilia Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Hemophilia Treatment Market Size Market Share by Type (2017-2022)
2.4 Hemophilia Treatment Segment by Application
2.4.1 Replacement Therapy
2.4.2 ITI Therapy
2.4.3 Gene Therapy
2.5 Hemophilia Treatment Market Size by Application
2.5.1 Hemophilia Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Hemophilia Treatment Market Size Market Share by Application (2017-2022)
3 Hemophilia Treatment Market Size by Player
3.1 Hemophilia Treatment Market Size Market Share by Players
3.1.1 Global Hemophilia Treatment Revenue by Players (2020-2022)
3.1.2 Global Hemophilia Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Hemophilia Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Hemophilia Treatment by Regions
4.1 Hemophilia Treatment Market Size by Regions (2017-2022)
4.2 Americas Hemophilia Treatment Market Size Growth (2017-2022)
4.3 APAC Hemophilia Treatment Market Size Growth (2017-2022)
4.4 Europe Hemophilia Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Hemophilia Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Hemophilia Treatment Market Size by Country (2017-2022)
5.2 Americas Hemophilia Treatment Market Size by Type (2017-2022)
5.3 Americas Hemophilia Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemophilia Treatment Market Size by Region (2017-2022)
6.2 APAC Hemophilia Treatment Market Size by Type (2017-2022)
6.3 APAC Hemophilia Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Hemophilia Treatment by Country (2017-2022)
7.2 Europe Hemophilia Treatment Market Size by Type (2017-2022)
7.3 Europe Hemophilia Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hemophilia Treatment by Region (2017-2022)
8.2 Middle East & Africa Hemophilia Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Hemophilia Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Hemophilia Treatment Market Forecast
10.1 Global Hemophilia Treatment Forecast by Regions (2023-2028)
10.1.1 Global Hemophilia Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Hemophilia Treatment Forecast
10.1.3 APAC Hemophilia Treatment Forecast
10.1.4 Europe Hemophilia Treatment Forecast
10.1.5 Middle East & Africa Hemophilia Treatment Forecast
10.2 Americas Hemophilia Treatment Forecast by Country (2023-2028)
10.2.1 United States Hemophilia Treatment Market Forecast
10.2.2 Canada Hemophilia Treatment Market Forecast
10.2.3 Mexico Hemophilia Treatment Market Forecast
10.2.4 Brazil Hemophilia Treatment Market Forecast
10.3 APAC Hemophilia Treatment Forecast by Region (2023-2028)
10.3.1 China Hemophilia Treatment Market Forecast
10.3.2 Japan Hemophilia Treatment Market Forecast
10.3.3 Korea Hemophilia Treatment Market Forecast
10.3.4 Southeast Asia Hemophilia Treatment Market Forecast
10.3.5 India Hemophilia Treatment Market Forecast
10.3.6 Australia Hemophilia Treatment Market Forecast
10.4 Europe Hemophilia Treatment Forecast by Country (2023-2028)
10.4.1 Germany Hemophilia Treatment Market Forecast
10.4.2 France Hemophilia Treatment Market Forecast
10.4.3 UK Hemophilia Treatment Market Forecast
10.4.4 Italy Hemophilia Treatment Market Forecast
10.4.5 Russia Hemophilia Treatment Market Forecast
10.5 Middle East & Africa Hemophilia Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Hemophilia Treatment Market Forecast
10.5.2 South Africa Hemophilia Treatment Market Forecast
10.5.3 Israel Hemophilia Treatment Market Forecast
10.5.4 Turkey Hemophilia Treatment Market Forecast
10.5.5 GCC Countries Hemophilia Treatment Market Forecast
10.6 Global Hemophilia Treatment Forecast by Type (2023-2028)
10.7 Global Hemophilia Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 CSL Behring
11.1.1 CSL Behring Company Information
11.1.2 CSL Behring Hemophilia Treatment Product Offered
11.1.3 CSL Behring Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 CSL Behring Main Business Overview
11.1.5 CSL Behring Latest Developments
11.2 Baxalta
11.2.1 Baxalta Company Information
11.2.2 Baxalta Hemophilia Treatment Product Offered
11.2.3 Baxalta Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Baxalta Main Business Overview
11.2.5 Baxalta Latest Developments
11.3 Pfizer Inc
11.3.1 Pfizer Inc Company Information
11.3.2 Pfizer Inc Hemophilia Treatment Product Offered
11.3.3 Pfizer Inc Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Inc Main Business Overview
11.3.5 Pfizer Inc Latest Developments
11.4 BioMarin
11.4.1 BioMarin Company Information
11.4.2 BioMarin Hemophilia Treatment Product Offered
11.4.3 BioMarin Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 BioMarin Main Business Overview
11.4.5 BioMarin Latest Developments
11.5 Bayer Healthcare
11.5.1 Bayer Healthcare Company Information
11.5.2 Bayer Healthcare Hemophilia Treatment Product Offered
11.5.3 Bayer Healthcare Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bayer Healthcare Main Business Overview
11.5.5 Bayer Healthcare Latest Developments
11.6 Biogen
11.6.1 Biogen Company Information
11.6.2 Biogen Hemophilia Treatment Product Offered
11.6.3 Biogen Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Biogen Main Business Overview
11.6.5 Biogen Latest Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Information
11.7.2 Novo Nordisk Hemophilia Treatment Product Offered
11.7.3 Novo Nordisk Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Novo Nordisk Main Business Overview
11.7.5 Novo Nordisk Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Hemophilia Treatment Product Offered
11.8.3 Roche Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 Takeda
11.9.1 Takeda Company Information
11.9.2 Takeda Hemophilia Treatment Product Offered
11.9.3 Takeda Hemophilia Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Takeda Main Business Overview
11.9.5 Takeda Latest Developments
12 Research Findings and Conclusion
Table 1. Hemophilia Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of On-demand
Table 3. Major Players of Prophylaxis
Table 4. Hemophilia Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Hemophilia Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Hemophilia Treatment Market Size Market Share by Type (2017-2022)
Table 7. Hemophilia Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Hemophilia Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Hemophilia Treatment Market Size Market Share by Application (2017-2022)
Table 10. Global Hemophilia Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Hemophilia Treatment Revenue Market Share by Player (2020-2022)
Table 12. Hemophilia Treatment Key Players Head office and Products Offered
Table 13. Hemophilia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Hemophilia Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Hemophilia Treatment Market Size Market Share by Regions (2017-2022)
Table 18. Americas Hemophilia Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Hemophilia Treatment Market Size Market Share by Country (2017-2022)
Table 20. Americas Hemophilia Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Hemophilia Treatment Market Size Market Share by Type (2017-2022)
Table 22. Americas Hemophilia Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Hemophilia Treatment Market Size Market Share by Application (2017-2022)
Table 24. APAC Hemophilia Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Hemophilia Treatment Market Size Market Share by Region (2017-2022)
Table 26. APAC Hemophilia Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Hemophilia Treatment Market Size Market Share by Type (2017-2022)
Table 28. APAC Hemophilia Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Hemophilia Treatment Market Size Market Share by Application (2017-2022)
Table 30. Europe Hemophilia Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Hemophilia Treatment Market Size Market Share by Country (2017-2022)
Table 32. Europe Hemophilia Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Hemophilia Treatment Market Size Market Share by Type (2017-2022)
Table 34. Europe Hemophilia Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Hemophilia Treatment Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Hemophilia Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Hemophilia Treatment Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Hemophilia Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Hemophilia Treatment Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Hemophilia Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Hemophilia Treatment Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Hemophilia Treatment
Table 43. Key Market Challenges & Risks of Hemophilia Treatment
Table 44. Key Industry Trends of Hemophilia Treatment
Table 45. Global Hemophilia Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Hemophilia Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Hemophilia Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Hemophilia Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Hemophilia Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Hemophilia Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 51. CSL Behring Details, Company Type, Hemophilia Treatment Area Served and Its Competitors
Table 52. CSL Behring Hemophilia Treatment Product Offered
Table 53. CSL Behring Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. CSL Behring Main Business
Table 55. CSL Behring Latest Developments
Table 56. Baxalta Details, Company Type, Hemophilia Treatment Area Served and Its Competitors
Table 57. Baxalta Hemophilia Treatment Product Offered
Table 58. Baxalta Main Business
Table 59. Baxalta Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Baxalta Latest Developments
Table 61. Pfizer Inc Details, Company Type, Hemophilia Treatment Area Served and Its Competitors
Table 62. Pfizer Inc Hemophilia Treatment Product Offered
Table 63. Pfizer Inc Main Business
Table 64. Pfizer Inc Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Pfizer Inc Latest Developments
Table 66. BioMarin Details, Company Type, Hemophilia Treatment Area Served and Its Competitors
Table 67. BioMarin Hemophilia Treatment Product Offered
Table 68. BioMarin Main Business
Table 69. BioMarin Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. BioMarin Latest Developments
Table 71. Bayer Healthcare Details, Company Type, Hemophilia Treatment Area Served and Its Competitors
Table 72. Bayer Healthcare Hemophilia Treatment Product Offered
Table 73. Bayer Healthcare Main Business
Table 74. Bayer Healthcare Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Bayer Healthcare Latest Developments
Table 76. Biogen Details, Company Type, Hemophilia Treatment Area Served and Its Competitors
Table 77. Biogen Hemophilia Treatment Product Offered
Table 78. Biogen Main Business
Table 79. Biogen Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Biogen Latest Developments
Table 81. Novo Nordisk Details, Company Type, Hemophilia Treatment Area Served and Its Competitors
Table 82. Novo Nordisk Hemophilia Treatment Product Offered
Table 83. Novo Nordisk Main Business
Table 84. Novo Nordisk Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Novo Nordisk Latest Developments
Table 86. Roche Details, Company Type, Hemophilia Treatment Area Served and Its Competitors
Table 87. Roche Hemophilia Treatment Product Offered
Table 88. Roche Main Business
Table 89. Roche Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Roche Latest Developments
Table 91. Takeda Details, Company Type, Hemophilia Treatment Area Served and Its Competitors
Table 92. Takeda Hemophilia Treatment Product Offered
Table 93. Takeda Main Business
Table 94. Takeda Hemophilia Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Takeda Latest Developments
List of Figures
Figure 1. Hemophilia Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hemophilia Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Hemophilia Treatment Market Size Market Share by Type in 2021
Figure 7. Hemophilia Treatment in Replacement Therapy
Figure 8. Global Hemophilia Treatment Market: Replacement Therapy (2017-2022) & ($ Millions)
Figure 9. Hemophilia Treatment in ITI Therapy
Figure 10. Global Hemophilia Treatment Market: ITI Therapy (2017-2022) & ($ Millions)
Figure 11. Hemophilia Treatment in Gene Therapy
Figure 12. Global Hemophilia Treatment Market: Gene Therapy (2017-2022) & ($ Millions)
Figure 13. Global Hemophilia Treatment Market Size Market Share by Application in 2021
Figure 14. Global Hemophilia Treatment Revenue Market Share by Player in 2021
Figure 15. Global Hemophilia Treatment Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Hemophilia Treatment Market Size 2017-2022 ($ Millions)
Figure 17. APAC Hemophilia Treatment Market Size 2017-2022 ($ Millions)
Figure 18. Europe Hemophilia Treatment Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Hemophilia Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Americas Hemophilia Treatment Value Market Share by Country in 2021
Figure 21. Americas Hemophilia Treatment Consumption Market Share by Type in 2021
Figure 22. Americas Hemophilia Treatment Market Size Market Share by Application in 2021
Figure 23. United States Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Hemophilia Treatment Market Size Market Share by Region in 2021
Figure 28. APAC Hemophilia Treatment Market Size Market Share by Application in 2021
Figure 29. China Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Hemophilia Treatment Market Size Market Share by Country in 2021
Figure 36. Europe Hemophilia Treatment Market Size Market Share by Type in 2021
Figure 37. Europe Hemophilia Treatment Market Size Market Share by Application in 2021
Figure 38. Germany Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Hemophilia Treatment Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Hemophilia Treatment Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Hemophilia Treatment Market Size Market Share by Application in 2021
Figure 46. Egypt Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Hemophilia Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 52. APAC Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 53. Europe Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 55. United States Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Canada Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 59. China Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Japan Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Korea Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 63. India Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Australia Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Germany Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 66. France Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 67. UK Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Italy Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Russia Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Spain Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Israel Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Hemophilia Treatment Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
